Implicated product is expired.A dhr review was performed on capture r ready id, lot id298 for fya antigen status prior to release.Cells 2,3,6,7,9,12 and 14 are listed as fya + on the masterlist.Dhr quality review deemed all specifications as being met and released product to market on 26apr20.
Event or Problem Description
On (b)(6) 2016, a customer reported an unexpected negative result when testing patient sample (b)(6) with capture-r ready-id lot id298 on the galileo echo instrument.